The treatment of Alzheimer’s disease has been a long-standing challenge and area of interest. The knowledge in pathogenesis and an increased disease burden have prompted innovative therapeutics over the last two decades.
There are six drugs approved by Food and Drug Administration (FDA) for the treatment, but there is no cure for Alzheimer’s disease despite all scientific efforts and many protracted and expensive clinical trials.
